Addressing threats to health care's core values, especially those stemming from concentration and abuse of power - and now larger threats to the democracy needed to advance health and welfare. Advocating for accountability, integrity, transparency, honesty and ethics in leadership and governance of health care.
Pages
▼
Friday, February 29, 2008
BLOGSCAN - Dubious Clinical "Researchers"
On the Clinical Psychology and Psychiatry Blog, two posts (here and here) gave examples of how the physicians pharmaceutical and biotechnology companies hire to implement their clinical trials may not always be qualified or competent to do such work, to put it politely. Despite some egregious conduct by such "researchers," the US Food and Drug Administration (FDA) has been slow to take action against them, and presumably the data they produce may still be used to argue for the advantages or particular drugs.
With this post on rsearchers, It is mentioned that the FDA has been slow to take action against such researchers. This premise may be faulty, because it posits that the FDA desires to take action against them.
ReplyDelete